ARCHIVES

FDA will return memento given to McClellan by NCI Director Andrew von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 30 No. 06 | February 6, 2004

Download PDF Visit The Full Archive

Related Articles

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005

In Brief: Rosenberg, Taniguchi To Share Hammer 1985 Prize; Dennis Cain Moves To DCT From DEA Grants Review

December 6, 1985

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

In Brief: Monaco, Yarbro Named To Pharmacopeial Board; Gene Therapy Trial For ADA Clears First Hurdle

March 23, 1990

New Saccharin Studies Convince FDA It A Carcinogen

July 15, 1977

AHCPR Funds Centers to Review Practice

July 4, 1997